nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—breast cancer	0.224	1	CbGaD
Rifaximin—NR1I2—Paclitaxel—breast cancer	0.162	0.311	CbGbCtD
Rifaximin—NR1I2—Docetaxel—breast cancer	0.117	0.225	CbGbCtD
Rifaximin—CYP3A4—Exemestane—breast cancer	0.0323	0.0618	CbGbCtD
Rifaximin—CYP3A4—Letrozole—breast cancer	0.0274	0.0525	CbGbCtD
Rifaximin—CYP3A4—Anastrozole—breast cancer	0.0245	0.0468	CbGbCtD
Rifaximin—CYP3A4—Toremifene—breast cancer	0.0224	0.0428	CbGbCtD
Rifaximin—CYP3A4—Fulvestrant—breast cancer	0.0208	0.0398	CbGbCtD
Rifaximin—CYP3A4—Thiotepa—breast cancer	0.0185	0.0355	CbGbCtD
Rifaximin—CYP3A4—Ixabepilone—breast cancer	0.0169	0.0325	CbGbCtD
Rifaximin—CYP3A4—Lapatinib—breast cancer	0.0163	0.0312	CbGbCtD
Rifaximin—CYP3A4—Raloxifene—breast cancer	0.0124	0.0237	CbGbCtD
Rifaximin—CYP3A4—Vinorelbine—breast cancer	0.00905	0.0173	CbGbCtD
Rifaximin—CYP3A4—Tamoxifen—breast cancer	0.00817	0.0156	CbGbCtD
Rifaximin—CYP3A4—Mitoxantrone—breast cancer	0.00797	0.0153	CbGbCtD
Rifaximin—CYP3A4—Paclitaxel—breast cancer	0.00636	0.0122	CbGbCtD
Rifaximin—CYP3A4—Irinotecan—breast cancer	0.00627	0.012	CbGbCtD
Rifaximin—CYP3A4—Vinblastine—breast cancer	0.00558	0.0107	CbGbCtD
Rifaximin—CYP3A4—Docetaxel—breast cancer	0.0046	0.0088	CbGbCtD
Rifaximin—Rifabutin—HSP90AA1—breast cancer	0.00363	0.64	CrCbGaD
Rifaximin—CYP3A4—Doxorubicin—breast cancer	0.00343	0.00656	CbGbCtD
Rifaximin—Rifampicin—SLCO1B1—breast cancer	0.000593	0.105	CrCbGaD
Rifaximin—Rifampicin—ABCC1—breast cancer	0.00049	0.0864	CrCbGaD
Rifaximin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—breast cancer	0.000273	0.00417	CbGpPWpGaD
Rifaximin—Rifabutin—CYP3A4—breast cancer	0.000273	0.0481	CrCbGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ESRRA—breast cancer	0.000266	0.00406	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—SULT1A1—breast cancer	0.000257	0.00392	CbGpPWpGaD
Rifaximin—Rifapentine—CYP2D6—breast cancer	0.000241	0.0425	CrCbGaD
Rifaximin—NR1I2—Generic Transcription Pathway—THRB—breast cancer	0.00024	0.00367	CbGpPWpGaD
Rifaximin—CYP3A4—Irinotecan Pathway—BCHE—breast cancer	0.000232	0.00354	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—RXRB—breast cancer	0.00023	0.00352	CbGpPWpGaD
Rifaximin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—breast cancer	0.000229	0.00349	CbGpPWpGaD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—breast cancer	0.00022	0.00335	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HNRNPK—breast cancer	0.000211	0.00322	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HNRNPR—breast cancer	0.000211	0.00322	CbGpPWpGaD
Rifaximin—Rifapentine—CYP3A4—breast cancer	0.000207	0.0365	CrCbGaD
Rifaximin—NR1I2—Gene Expression—NR2F1—breast cancer	0.000193	0.00295	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—EEF1B2—breast cancer	0.000193	0.00295	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—breast cancer	0.000186	0.00283	CbGpPWpGaD
Rifaximin—CYP3A4—Xenobiotics—CYP2D6—breast cancer	0.000184	0.0028	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—breast cancer	0.000183	0.0028	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—NQO1—breast cancer	0.000181	0.00276	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HNF4G—breast cancer	0.00018	0.00274	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR2F6—breast cancer	0.00018	0.00274	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP2D6—breast cancer	0.000177	0.0027	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—ALDH1A1—breast cancer	0.000175	0.00267	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—CYP1B1—breast cancer	0.000173	0.00265	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—RARB—breast cancer	0.000167	0.00254	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HNRNPL—breast cancer	0.00016	0.00244	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—MED12—breast cancer	0.00016	0.00244	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—breast cancer	0.000154	0.00235	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP1B1—breast cancer	0.000153	0.00234	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—COMT—breast cancer	0.000152	0.00231	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—breast cancer	0.000149	0.00228	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—breast cancer	0.000149	0.00228	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NOTCH4—breast cancer	0.000145	0.00221	CbGpPWpGaD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—breast cancer	0.000144	0.0022	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—GSTM1—breast cancer	0.000139	0.00212	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PGR—breast cancer	0.000132	0.00202	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—EIF2S2—breast cancer	0.000132	0.00201	CbGpPWpGaD
Rifaximin—CYP3A4—Estrogen metabolism—CYP1A1—breast cancer	0.000131	0.00201	CbGpPWpGaD
Rifaximin—Rifampicin—CYP3A4—breast cancer	0.000129	0.0228	CrCbGaD
Rifaximin—NR1I2—Gene Expression—ESRRA—breast cancer	0.000128	0.00195	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NCOA2—breast cancer	0.000127	0.00194	CbGpPWpGaD
Rifaximin—CYP3A4—Irinotecan Pathway—APC—breast cancer	0.000126	0.00192	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—breast cancer	0.000124	0.00189	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—PARP1—breast cancer	0.000123	0.00188	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NOTCH3—breast cancer	0.000123	0.00188	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—YBX1—breast cancer	0.000121	0.00185	CbGpPWpGaD
Rifaximin—CYP3A4—Xenobiotics—CYP1A1—breast cancer	0.000121	0.00184	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ESR2—breast cancer	0.000117	0.00178	CbGpPWpGaD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP1A1—breast cancer	0.000116	0.00177	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—EEF2—breast cancer	0.000116	0.00177	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—THRB—breast cancer	0.000116	0.00177	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—breast cancer	0.000115	0.00175	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—TET2—breast cancer	0.000111	0.00169	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RXRB—breast cancer	0.000111	0.00169	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NOTCH2—breast cancer	0.00011	0.00168	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPL31—breast cancer	0.000109	0.00166	CbGpPWpGaD
Rifaximin—Rifampicin—ABCB1—breast cancer	0.000107	0.0189	CrCbGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NCOA1—breast cancer	0.000107	0.00164	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—breast cancer	0.000107	0.00164	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—breast cancer	0.000104	0.00159	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—AR—breast cancer	0.000103	0.00157	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPS4X—breast cancer	0.000101	0.00155	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—EIF3A—breast cancer	9.99e-05	0.00152	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—DNMT3A—breast cancer	9.84e-05	0.0015	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ELL—breast cancer	9.7e-05	0.00148	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—SMAD4—breast cancer	9.27e-05	0.00141	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—VDR—breast cancer	9.25e-05	0.00141	CbGpPWpGaD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—breast cancer	9.01e-05	0.00137	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NCOR1—breast cancer	9e-05	0.00137	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PABPC1—breast cancer	8.97e-05	0.00137	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CHST9—breast cancer	8.76e-05	0.00134	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—breast cancer	8.58e-05	0.00131	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—breast cancer	8.57e-05	0.00131	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—DNMT3B—breast cancer	8.41e-05	0.00128	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPL23A—breast cancer	8.25e-05	0.00126	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP1B1—breast cancer	8.18e-05	0.00125	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HIST1H2BK—breast cancer	8.09e-05	0.00124	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HIST1H2BC—breast cancer	8.09e-05	0.00124	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RARB—breast cancer	8.02e-05	0.00122	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—breast cancer	7.86e-05	0.0012	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—breast cancer	7.76e-05	0.00118	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP19A1—breast cancer	7.69e-05	0.00117	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPS8—breast cancer	7.69e-05	0.00117	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPS7—breast cancer	7.69e-05	0.00117	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—MED12—breast cancer	7.69e-05	0.00117	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—breast cancer	7.63e-05	0.00116	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—breast cancer	7.53e-05	0.00115	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	7.49e-05	0.00114	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ESR1—breast cancer	7.07e-05	0.00108	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NOTCH4—breast cancer	6.97e-05	0.00106	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NOTCH1—breast cancer	6.83e-05	0.00104	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—HSPA1B—breast cancer	6.65e-05	0.00101	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	6.62e-05	0.00101	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—breast cancer	6.53e-05	0.000997	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	6.37e-05	0.000973	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PGR—breast cancer	6.37e-05	0.000972	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	6.31e-05	0.000963	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	6.31e-05	0.000963	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—DNMT1—breast cancer	6.25e-05	0.000954	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	6.22e-05	0.000949	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP1A1—breast cancer	6.2e-05	0.000947	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	6.19e-05	0.000944	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—breast cancer	6.14e-05	0.000937	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NCOA2—breast cancer	6.13e-05	0.000936	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—ALDH1A1—breast cancer	6.09e-05	0.000929	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	6.07e-05	0.000927	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—EZH2—breast cancer	6.05e-05	0.000924	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NOTCH3—breast cancer	5.92e-05	0.000904	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PARP1—breast cancer	5.92e-05	0.000904	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—SERPINE1—breast cancer	5.81e-05	0.000886	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—RPS6—breast cancer	5.78e-05	0.000882	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ESR2—breast cancer	5.61e-05	0.000856	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTA3—breast cancer	5.42e-05	0.000828	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	5.36e-05	0.000819	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	5.35e-05	0.000816	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NOTCH2—breast cancer	5.31e-05	0.000811	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NCOA1—breast cancer	5.17e-05	0.000789	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	5.12e-05	0.000781	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	5.04e-05	0.00077	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	5.01e-05	0.000765	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTA4—breast cancer	4.96e-05	0.000757	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AR—breast cancer	4.96e-05	0.000756	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	4.95e-05	0.000755	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	4.89e-05	0.000747	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GSTA2—breast cancer	4.83e-05	0.000738	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—SULT1A1—breast cancer	4.78e-05	0.000729	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	4.77e-05	0.000728	CbGpPWpGaD
Rifaximin—Skin disorder—Capecitabine—breast cancer	4.75e-05	0.000261	CcSEcCtD
Rifaximin—Urinary tract disorder—Epirubicin—breast cancer	4.73e-05	0.00026	CcSEcCtD
Rifaximin—Urticaria—Paclitaxel—breast cancer	4.73e-05	0.00026	CcSEcCtD
Rifaximin—Hyperhidrosis—Capecitabine—breast cancer	4.72e-05	0.000259	CcSEcCtD
Rifaximin—Oedema peripheral—Epirubicin—breast cancer	4.72e-05	0.000259	CcSEcCtD
Rifaximin—Hypotension—Docetaxel—breast cancer	4.72e-05	0.000259	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	4.71e-05	0.000719	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	4.71e-05	0.000719	CbGpPWpGaD
Rifaximin—Haematuria—Doxorubicin—breast cancer	4.71e-05	0.000258	CcSEcCtD
Rifaximin—Body temperature increased—Paclitaxel—breast cancer	4.71e-05	0.000258	CcSEcCtD
Rifaximin—Abdominal pain—Paclitaxel—breast cancer	4.71e-05	0.000258	CcSEcCtD
Rifaximin—Urethral disorder—Epirubicin—breast cancer	4.7e-05	0.000258	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—GSTA1—breast cancer	4.66e-05	0.000712	CbGpPWpGaD
Rifaximin—Epistaxis—Doxorubicin—breast cancer	4.66e-05	0.000256	CcSEcCtD
Rifaximin—Anorexia—Capecitabine—breast cancer	4.66e-05	0.000256	CcSEcCtD
Rifaximin—Angiopathy—Methotrexate—breast cancer	4.65e-05	0.000255	CcSEcCtD
Rifaximin—Vomiting—Irinotecan—breast cancer	4.64e-05	0.000255	CcSEcCtD
Rifaximin—Vomiting—Mitoxantrone—breast cancer	4.64e-05	0.000255	CcSEcCtD
Rifaximin—Dizziness—Fluorouracil—breast cancer	4.62e-05	0.000254	CcSEcCtD
Rifaximin—Mediastinal disorder—Methotrexate—breast cancer	4.62e-05	0.000253	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—NAT2—breast cancer	4.61e-05	0.000704	CbGpPWpGaD
Rifaximin—Rash—Irinotecan—breast cancer	4.6e-05	0.000253	CcSEcCtD
Rifaximin—Rash—Mitoxantrone—breast cancer	4.6e-05	0.000253	CcSEcCtD
Rifaximin—Dermatitis—Irinotecan—breast cancer	4.6e-05	0.000252	CcSEcCtD
Rifaximin—Dermatitis—Mitoxantrone—breast cancer	4.6e-05	0.000252	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Docetaxel—breast cancer	4.6e-05	0.000252	CcSEcCtD
Rifaximin—Headache—Mitoxantrone—breast cancer	4.57e-05	0.000251	CcSEcCtD
Rifaximin—Headache—Irinotecan—breast cancer	4.57e-05	0.000251	CcSEcCtD
Rifaximin—Hypotension—Capecitabine—breast cancer	4.57e-05	0.000251	CcSEcCtD
Rifaximin—Insomnia—Docetaxel—breast cancer	4.57e-05	0.000251	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	4.55e-05	0.000694	CbGpPWpGaD
Rifaximin—Vomiting—Gemcitabine—breast cancer	4.52e-05	0.000248	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—SIRT1—breast cancer	4.52e-05	0.000689	CbGpPWpGaD
Rifaximin—Dyspnoea—Docetaxel—breast cancer	4.5e-05	0.000247	CcSEcCtD
Rifaximin—Mental disorder—Methotrexate—breast cancer	4.49e-05	0.000246	CcSEcCtD
Rifaximin—Rash—Gemcitabine—breast cancer	4.49e-05	0.000246	CcSEcCtD
Rifaximin—Dermatitis—Gemcitabine—breast cancer	4.48e-05	0.000246	CcSEcCtD
Rifaximin—Tinnitus—Epirubicin—breast cancer	4.47e-05	0.000245	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—SMAD4—breast cancer	4.46e-05	0.000681	CbGpPWpGaD
Rifaximin—Malnutrition—Methotrexate—breast cancer	4.46e-05	0.000245	CcSEcCtD
Rifaximin—Haemoglobin—Doxorubicin—breast cancer	4.46e-05	0.000245	CcSEcCtD
Rifaximin—Headache—Gemcitabine—breast cancer	4.46e-05	0.000245	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Capecitabine—breast cancer	4.45e-05	0.000244	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—VDR—breast cancer	4.45e-05	0.000679	CbGpPWpGaD
Rifaximin—Flushing—Epirubicin—breast cancer	4.45e-05	0.000244	CcSEcCtD
Rifaximin—Vomiting—Fluorouracil—breast cancer	4.45e-05	0.000244	CcSEcCtD
Rifaximin—Rhinitis—Doxorubicin—breast cancer	4.45e-05	0.000244	CcSEcCtD
Rifaximin—Haemorrhage—Doxorubicin—breast cancer	4.43e-05	0.000243	CcSEcCtD
Rifaximin—Insomnia—Capecitabine—breast cancer	4.42e-05	0.000243	CcSEcCtD
Rifaximin—Hypoaesthesia—Doxorubicin—breast cancer	4.41e-05	0.000242	CcSEcCtD
Rifaximin—Rash—Fluorouracil—breast cancer	4.41e-05	0.000242	CcSEcCtD
Rifaximin—Dermatitis—Fluorouracil—breast cancer	4.41e-05	0.000242	CcSEcCtD
Rifaximin—Pharyngitis—Doxorubicin—breast cancer	4.4e-05	0.000242	CcSEcCtD
Rifaximin—Decreased appetite—Docetaxel—breast cancer	4.39e-05	0.000241	CcSEcCtD
Rifaximin—Hypersensitivity—Paclitaxel—breast cancer	4.39e-05	0.000241	CcSEcCtD
Rifaximin—Headache—Fluorouracil—breast cancer	4.38e-05	0.00024	CcSEcCtD
Rifaximin—Urinary tract disorder—Doxorubicin—breast cancer	4.38e-05	0.00024	CcSEcCtD
Rifaximin—Oedema peripheral—Doxorubicin—breast cancer	4.37e-05	0.00024	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Docetaxel—breast cancer	4.36e-05	0.000239	CcSEcCtD
Rifaximin—Dyspnoea—Capecitabine—breast cancer	4.36e-05	0.000239	CcSEcCtD
Rifaximin—Fatigue—Docetaxel—breast cancer	4.35e-05	0.000239	CcSEcCtD
Rifaximin—Angiopathy—Epirubicin—breast cancer	4.35e-05	0.000239	CcSEcCtD
Rifaximin—Urethral disorder—Doxorubicin—breast cancer	4.35e-05	0.000239	CcSEcCtD
Rifaximin—Nausea—Mitoxantrone—breast cancer	4.34e-05	0.000238	CcSEcCtD
Rifaximin—Nausea—Irinotecan—breast cancer	4.34e-05	0.000238	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NCOR1—breast cancer	4.33e-05	0.000661	CbGpPWpGaD
Rifaximin—Mediastinal disorder—Epirubicin—breast cancer	4.32e-05	0.000237	CcSEcCtD
Rifaximin—Constipation—Docetaxel—breast cancer	4.32e-05	0.000237	CcSEcCtD
Rifaximin—Pain—Docetaxel—breast cancer	4.32e-05	0.000237	CcSEcCtD
Rifaximin—Back pain—Methotrexate—breast cancer	4.31e-05	0.000237	CcSEcCtD
Rifaximin—Asthenia—Paclitaxel—breast cancer	4.27e-05	0.000234	CcSEcCtD
Rifaximin—Decreased appetite—Capecitabine—breast cancer	4.25e-05	0.000233	CcSEcCtD
Rifaximin—Nausea—Gemcitabine—breast cancer	4.23e-05	0.000232	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—H2AFX—breast cancer	4.22e-05	0.000644	CbGpPWpGaD
Rifaximin—Gastrointestinal disorder—Capecitabine—breast cancer	4.22e-05	0.000232	CcSEcCtD
Rifaximin—Fatigue—Capecitabine—breast cancer	4.21e-05	0.000231	CcSEcCtD
Rifaximin—Pruritus—Paclitaxel—breast cancer	4.21e-05	0.000231	CcSEcCtD
Rifaximin—Mental disorder—Epirubicin—breast cancer	4.2e-05	0.00023	CcSEcCtD
Rifaximin—Pain—Capecitabine—breast cancer	4.18e-05	0.000229	CcSEcCtD
Rifaximin—Constipation—Capecitabine—breast cancer	4.18e-05	0.000229	CcSEcCtD
Rifaximin—Malnutrition—Epirubicin—breast cancer	4.17e-05	0.000229	CcSEcCtD
Rifaximin—Feeling abnormal—Docetaxel—breast cancer	4.16e-05	0.000228	CcSEcCtD
Rifaximin—Nausea—Fluorouracil—breast cancer	4.15e-05	0.000228	CcSEcCtD
Rifaximin—Ill-defined disorder—Methotrexate—breast cancer	4.14e-05	0.000227	CcSEcCtD
Rifaximin—Tinnitus—Doxorubicin—breast cancer	4.13e-05	0.000227	CcSEcCtD
Rifaximin—Gastrointestinal pain—Docetaxel—breast cancer	4.13e-05	0.000227	CcSEcCtD
Rifaximin—Anaemia—Methotrexate—breast cancer	4.12e-05	0.000226	CcSEcCtD
Rifaximin—Flushing—Doxorubicin—breast cancer	4.12e-05	0.000226	CcSEcCtD
Rifaximin—Flatulence—Epirubicin—breast cancer	4.11e-05	0.000226	CcSEcCtD
Rifaximin—Diarrhoea—Paclitaxel—breast cancer	4.07e-05	0.000224	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—ERCC2—breast cancer	4.07e-05	0.000621	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	4.07e-05	0.00062	CbGpPWpGaD
Rifaximin—Back pain—Epirubicin—breast cancer	4.04e-05	0.000221	CcSEcCtD
Rifaximin—Feeling abnormal—Capecitabine—breast cancer	4.03e-05	0.000221	CcSEcCtD
Rifaximin—Angiopathy—Doxorubicin—breast cancer	4.02e-05	0.000221	CcSEcCtD
Rifaximin—Malaise—Methotrexate—breast cancer	4.02e-05	0.000221	CcSEcCtD
Rifaximin—Muscle spasms—Epirubicin—breast cancer	4.01e-05	0.00022	CcSEcCtD
Rifaximin—Vertigo—Methotrexate—breast cancer	4.01e-05	0.00022	CcSEcCtD
Rifaximin—Gastrointestinal pain—Capecitabine—breast cancer	4e-05	0.000219	CcSEcCtD
Rifaximin—Mediastinal disorder—Doxorubicin—breast cancer	4e-05	0.000219	CcSEcCtD
Rifaximin—Body temperature increased—Docetaxel—breast cancer	3.99e-05	0.000219	CcSEcCtD
Rifaximin—Abdominal pain—Docetaxel—breast cancer	3.99e-05	0.000219	CcSEcCtD
Rifaximin—Dizziness—Paclitaxel—breast cancer	3.94e-05	0.000216	CcSEcCtD
Rifaximin—Cough—Methotrexate—breast cancer	3.89e-05	0.000213	CcSEcCtD
Rifaximin—Mental disorder—Doxorubicin—breast cancer	3.88e-05	0.000213	CcSEcCtD
Rifaximin—Urticaria—Capecitabine—breast cancer	3.88e-05	0.000213	CcSEcCtD
Rifaximin—Ill-defined disorder—Epirubicin—breast cancer	3.87e-05	0.000212	CcSEcCtD
Rifaximin—Abdominal pain—Capecitabine—breast cancer	3.86e-05	0.000212	CcSEcCtD
Rifaximin—Body temperature increased—Capecitabine—breast cancer	3.86e-05	0.000212	CcSEcCtD
Rifaximin—Malnutrition—Doxorubicin—breast cancer	3.86e-05	0.000212	CcSEcCtD
Rifaximin—Anaemia—Epirubicin—breast cancer	3.86e-05	0.000212	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	3.83e-05	0.000584	CbGpPWpGaD
Rifaximin—Flatulence—Doxorubicin—breast cancer	3.8e-05	0.000209	CcSEcCtD
Rifaximin—Myalgia—Methotrexate—breast cancer	3.8e-05	0.000208	CcSEcCtD
Rifaximin—Chest pain—Methotrexate—breast cancer	3.8e-05	0.000208	CcSEcCtD
Rifaximin—Arthralgia—Methotrexate—breast cancer	3.8e-05	0.000208	CcSEcCtD
Rifaximin—Vomiting—Paclitaxel—breast cancer	3.79e-05	0.000208	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.77e-05	0.000207	CcSEcCtD
Rifaximin—Malaise—Epirubicin—breast cancer	3.76e-05	0.000206	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—MTR—breast cancer	3.76e-05	0.000574	CbGpPWpGaD
Rifaximin—Rash—Paclitaxel—breast cancer	3.76e-05	0.000206	CcSEcCtD
Rifaximin—Dermatitis—Paclitaxel—breast cancer	3.75e-05	0.000206	CcSEcCtD
Rifaximin—Discomfort—Methotrexate—breast cancer	3.75e-05	0.000206	CcSEcCtD
Rifaximin—Vertigo—Epirubicin—breast cancer	3.75e-05	0.000206	CcSEcCtD
Rifaximin—Syncope—Epirubicin—breast cancer	3.74e-05	0.000205	CcSEcCtD
Rifaximin—Back pain—Doxorubicin—breast cancer	3.73e-05	0.000205	CcSEcCtD
Rifaximin—Headache—Paclitaxel—breast cancer	3.73e-05	0.000205	CcSEcCtD
Rifaximin—Hypersensitivity—Docetaxel—breast cancer	3.72e-05	0.000204	CcSEcCtD
Rifaximin—Muscle spasms—Doxorubicin—breast cancer	3.71e-05	0.000204	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—HPGDS—breast cancer	3.69e-05	0.000563	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—MYC—breast cancer	3.68e-05	0.000561	CbGpPWpGaD
Rifaximin—Confusional state—Methotrexate—breast cancer	3.67e-05	0.000201	CcSEcCtD
Rifaximin—Loss of consciousness—Epirubicin—breast cancer	3.67e-05	0.000201	CcSEcCtD
Rifaximin—Cough—Epirubicin—breast cancer	3.64e-05	0.0002	CcSEcCtD
Rifaximin—Anaphylactic shock—Methotrexate—breast cancer	3.64e-05	0.0002	CcSEcCtD
Rifaximin—Asthenia—Docetaxel—breast cancer	3.62e-05	0.000199	CcSEcCtD
Rifaximin—Infection—Methotrexate—breast cancer	3.61e-05	0.000198	CcSEcCtD
Rifaximin—Hypersensitivity—Capecitabine—breast cancer	3.6e-05	0.000198	CcSEcCtD
Rifaximin—Ill-defined disorder—Doxorubicin—breast cancer	3.58e-05	0.000197	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—GSTT1—breast cancer	3.58e-05	0.000546	CbGpPWpGaD
Rifaximin—Pruritus—Docetaxel—breast cancer	3.57e-05	0.000196	CcSEcCtD
Rifaximin—Nervous system disorder—Methotrexate—breast cancer	3.57e-05	0.000196	CcSEcCtD
Rifaximin—Anaemia—Doxorubicin—breast cancer	3.57e-05	0.000196	CcSEcCtD
Rifaximin—Arthralgia—Epirubicin—breast cancer	3.55e-05	0.000195	CcSEcCtD
Rifaximin—Chest pain—Epirubicin—breast cancer	3.55e-05	0.000195	CcSEcCtD
Rifaximin—Myalgia—Epirubicin—breast cancer	3.55e-05	0.000195	CcSEcCtD
Rifaximin—Nausea—Paclitaxel—breast cancer	3.54e-05	0.000194	CcSEcCtD
Rifaximin—Skin disorder—Methotrexate—breast cancer	3.53e-05	0.000194	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.53e-05	0.000194	CcSEcCtD
Rifaximin—Hyperhidrosis—Methotrexate—breast cancer	3.52e-05	0.000193	CcSEcCtD
Rifaximin—Discomfort—Epirubicin—breast cancer	3.51e-05	0.000193	CcSEcCtD
Rifaximin—Asthenia—Capecitabine—breast cancer	3.51e-05	0.000192	CcSEcCtD
Rifaximin—Malaise—Doxorubicin—breast cancer	3.48e-05	0.000191	CcSEcCtD
Rifaximin—Dry mouth—Epirubicin—breast cancer	3.47e-05	0.000191	CcSEcCtD
Rifaximin—Vertigo—Doxorubicin—breast cancer	3.47e-05	0.00019	CcSEcCtD
Rifaximin—Anorexia—Methotrexate—breast cancer	3.47e-05	0.00019	CcSEcCtD
Rifaximin—Syncope—Doxorubicin—breast cancer	3.46e-05	0.00019	CcSEcCtD
Rifaximin—Pruritus—Capecitabine—breast cancer	3.46e-05	0.00019	CcSEcCtD
Rifaximin—Diarrhoea—Docetaxel—breast cancer	3.45e-05	0.00019	CcSEcCtD
Rifaximin—Confusional state—Epirubicin—breast cancer	3.43e-05	0.000188	CcSEcCtD
Rifaximin—Anaphylactic shock—Epirubicin—breast cancer	3.4e-05	0.000187	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—ESR1—breast cancer	3.4e-05	0.000519	CbGpPWpGaD
Rifaximin—Hypotension—Methotrexate—breast cancer	3.4e-05	0.000187	CcSEcCtD
Rifaximin—Loss of consciousness—Doxorubicin—breast cancer	3.39e-05	0.000186	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—CYP17A1—breast cancer	3.39e-05	0.000517	CbGpPWpGaD
Rifaximin—Infection—Epirubicin—breast cancer	3.38e-05	0.000186	CcSEcCtD
Rifaximin—Cough—Doxorubicin—breast cancer	3.37e-05	0.000185	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—PTGS1—breast cancer	3.35e-05	0.000511	CbGpPWpGaD
Rifaximin—Shock—Epirubicin—breast cancer	3.35e-05	0.000184	CcSEcCtD
Rifaximin—Diarrhoea—Capecitabine—breast cancer	3.34e-05	0.000184	CcSEcCtD
Rifaximin—Nervous system disorder—Epirubicin—breast cancer	3.34e-05	0.000183	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	3.34e-05	0.00051	CbGpPWpGaD
Rifaximin—Dizziness—Docetaxel—breast cancer	3.34e-05	0.000183	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Methotrexate—breast cancer	3.31e-05	0.000182	CcSEcCtD
Rifaximin—Skin disorder—Epirubicin—breast cancer	3.31e-05	0.000181	CcSEcCtD
Rifaximin—Hyperhidrosis—Epirubicin—breast cancer	3.29e-05	0.000181	CcSEcCtD
Rifaximin—Insomnia—Methotrexate—breast cancer	3.29e-05	0.000181	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—NOTCH1—breast cancer	3.29e-05	0.000502	CbGpPWpGaD
Rifaximin—Chest pain—Doxorubicin—breast cancer	3.29e-05	0.00018	CcSEcCtD
Rifaximin—Myalgia—Doxorubicin—breast cancer	3.29e-05	0.00018	CcSEcCtD
Rifaximin—Arthralgia—Doxorubicin—breast cancer	3.29e-05	0.00018	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—CYP2D6—breast cancer	3.29e-05	0.000502	CbGpPWpGaD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.26e-05	0.000179	CcSEcCtD
Rifaximin—Discomfort—Doxorubicin—breast cancer	3.25e-05	0.000178	CcSEcCtD
Rifaximin—Anorexia—Epirubicin—breast cancer	3.25e-05	0.000178	CcSEcCtD
Rifaximin—Dyspnoea—Methotrexate—breast cancer	3.24e-05	0.000178	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	3.24e-05	0.000495	CbGpPWpGaD
Rifaximin—Dizziness—Capecitabine—breast cancer	3.23e-05	0.000177	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—NCOA2—breast cancer	3.23e-05	0.000492	CbGpPWpGaD
Rifaximin—Dry mouth—Doxorubicin—breast cancer	3.21e-05	0.000176	CcSEcCtD
Rifaximin—Vomiting—Docetaxel—breast cancer	3.21e-05	0.000176	CcSEcCtD
Rifaximin—Rash—Docetaxel—breast cancer	3.18e-05	0.000175	CcSEcCtD
Rifaximin—Hypotension—Epirubicin—breast cancer	3.18e-05	0.000175	CcSEcCtD
Rifaximin—Dermatitis—Docetaxel—breast cancer	3.18e-05	0.000175	CcSEcCtD
Rifaximin—Confusional state—Doxorubicin—breast cancer	3.18e-05	0.000174	CcSEcCtD
Rifaximin—Decreased appetite—Methotrexate—breast cancer	3.16e-05	0.000174	CcSEcCtD
Rifaximin—Headache—Docetaxel—breast cancer	3.16e-05	0.000174	CcSEcCtD
Rifaximin—Anaphylactic shock—Doxorubicin—breast cancer	3.15e-05	0.000173	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Methotrexate—breast cancer	3.14e-05	0.000172	CcSEcCtD
Rifaximin—Fatigue—Methotrexate—breast cancer	3.14e-05	0.000172	CcSEcCtD
Rifaximin—Infection—Doxorubicin—breast cancer	3.13e-05	0.000172	CcSEcCtD
Rifaximin—Pain—Methotrexate—breast cancer	3.11e-05	0.000171	CcSEcCtD
Rifaximin—Vomiting—Capecitabine—breast cancer	3.11e-05	0.000171	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Epirubicin—breast cancer	3.1e-05	0.00017	CcSEcCtD
Rifaximin—Shock—Doxorubicin—breast cancer	3.1e-05	0.00017	CcSEcCtD
Rifaximin—Nervous system disorder—Doxorubicin—breast cancer	3.09e-05	0.00017	CcSEcCtD
Rifaximin—Rash—Capecitabine—breast cancer	3.08e-05	0.000169	CcSEcCtD
Rifaximin—Insomnia—Epirubicin—breast cancer	3.08e-05	0.000169	CcSEcCtD
Rifaximin—Dermatitis—Capecitabine—breast cancer	3.08e-05	0.000169	CcSEcCtD
Rifaximin—Headache—Capecitabine—breast cancer	3.06e-05	0.000168	CcSEcCtD
Rifaximin—Skin disorder—Doxorubicin—breast cancer	3.06e-05	0.000168	CcSEcCtD
Rifaximin—Hyperhidrosis—Doxorubicin—breast cancer	3.05e-05	0.000167	CcSEcCtD
Rifaximin—Dyspnoea—Epirubicin—breast cancer	3.04e-05	0.000167	CcSEcCtD
Rifaximin—Anorexia—Doxorubicin—breast cancer	3e-05	0.000165	CcSEcCtD
Rifaximin—Nausea—Docetaxel—breast cancer	3e-05	0.000165	CcSEcCtD
Rifaximin—Feeling abnormal—Methotrexate—breast cancer	3e-05	0.000165	CcSEcCtD
Rifaximin—Gastrointestinal pain—Methotrexate—breast cancer	2.98e-05	0.000163	CcSEcCtD
Rifaximin—Decreased appetite—Epirubicin—breast cancer	2.96e-05	0.000162	CcSEcCtD
Rifaximin—Hypotension—Doxorubicin—breast cancer	2.94e-05	0.000162	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Epirubicin—breast cancer	2.94e-05	0.000161	CcSEcCtD
Rifaximin—Fatigue—Epirubicin—breast cancer	2.94e-05	0.000161	CcSEcCtD
Rifaximin—Pain—Epirubicin—breast cancer	2.91e-05	0.00016	CcSEcCtD
Rifaximin—Constipation—Epirubicin—breast cancer	2.91e-05	0.00016	CcSEcCtD
Rifaximin—Nausea—Capecitabine—breast cancer	2.9e-05	0.000159	CcSEcCtD
Rifaximin—Urticaria—Methotrexate—breast cancer	2.89e-05	0.000159	CcSEcCtD
Rifaximin—Abdominal pain—Methotrexate—breast cancer	2.88e-05	0.000158	CcSEcCtD
Rifaximin—Body temperature increased—Methotrexate—breast cancer	2.88e-05	0.000158	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.87e-05	0.000158	CcSEcCtD
Rifaximin—Insomnia—Doxorubicin—breast cancer	2.85e-05	0.000156	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.85e-05	0.000435	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.81e-05	0.000429	CbGpPWpGaD
Rifaximin—Dyspnoea—Doxorubicin—breast cancer	2.81e-05	0.000154	CcSEcCtD
Rifaximin—Feeling abnormal—Epirubicin—breast cancer	2.81e-05	0.000154	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—SERPINE1—breast cancer	2.8e-05	0.000427	CbGpPWpGaD
Rifaximin—Gastrointestinal pain—Epirubicin—breast cancer	2.78e-05	0.000153	CcSEcCtD
Rifaximin—Decreased appetite—Doxorubicin—breast cancer	2.74e-05	0.00015	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Doxorubicin—breast cancer	2.72e-05	0.000149	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.72e-05	0.000415	CbGpPWpGaD
Rifaximin—Fatigue—Doxorubicin—breast cancer	2.72e-05	0.000149	CcSEcCtD
Rifaximin—Urticaria—Epirubicin—breast cancer	2.7e-05	0.000148	CcSEcCtD
Rifaximin—Constipation—Doxorubicin—breast cancer	2.69e-05	0.000148	CcSEcCtD
Rifaximin—Pain—Doxorubicin—breast cancer	2.69e-05	0.000148	CcSEcCtD
Rifaximin—Abdominal pain—Epirubicin—breast cancer	2.69e-05	0.000148	CcSEcCtD
Rifaximin—Body temperature increased—Epirubicin—breast cancer	2.69e-05	0.000148	CcSEcCtD
Rifaximin—Hypersensitivity—Methotrexate—breast cancer	2.68e-05	0.000147	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.68e-05	0.000409	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.64e-05	0.000403	CbGpPWpGaD
Rifaximin—Asthenia—Methotrexate—breast cancer	2.61e-05	0.000143	CcSEcCtD
Rifaximin—Feeling abnormal—Doxorubicin—breast cancer	2.6e-05	0.000142	CcSEcCtD
Rifaximin—Gastrointestinal pain—Doxorubicin—breast cancer	2.58e-05	0.000141	CcSEcCtD
Rifaximin—Pruritus—Methotrexate—breast cancer	2.57e-05	0.000141	CcSEcCtD
Rifaximin—Hypersensitivity—Epirubicin—breast cancer	2.51e-05	0.000138	CcSEcCtD
Rifaximin—Urticaria—Doxorubicin—breast cancer	2.5e-05	0.000137	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—COMT—breast cancer	2.49e-05	0.00038	CbGpPWpGaD
Rifaximin—Body temperature increased—Doxorubicin—breast cancer	2.49e-05	0.000137	CcSEcCtD
Rifaximin—Abdominal pain—Doxorubicin—breast cancer	2.49e-05	0.000137	CcSEcCtD
Rifaximin—Diarrhoea—Methotrexate—breast cancer	2.49e-05	0.000137	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.48e-05	0.000378	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.46e-05	0.000375	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.44e-05	0.000373	CbGpPWpGaD
Rifaximin—Asthenia—Epirubicin—breast cancer	2.44e-05	0.000134	CcSEcCtD
Rifaximin—Pruritus—Epirubicin—breast cancer	2.41e-05	0.000132	CcSEcCtD
Rifaximin—Dizziness—Methotrexate—breast cancer	2.41e-05	0.000132	CcSEcCtD
Rifaximin—Diarrhoea—Epirubicin—breast cancer	2.33e-05	0.000128	CcSEcCtD
Rifaximin—Hypersensitivity—Doxorubicin—breast cancer	2.32e-05	0.000127	CcSEcCtD
Rifaximin—Vomiting—Methotrexate—breast cancer	2.31e-05	0.000127	CcSEcCtD
Rifaximin—Rash—Methotrexate—breast cancer	2.29e-05	0.000126	CcSEcCtD
Rifaximin—Dermatitis—Methotrexate—breast cancer	2.29e-05	0.000126	CcSEcCtD
Rifaximin—Headache—Methotrexate—breast cancer	2.28e-05	0.000125	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.28e-05	0.000348	CbGpPWpGaD
Rifaximin—Asthenia—Doxorubicin—breast cancer	2.26e-05	0.000124	CcSEcCtD
Rifaximin—Dizziness—Epirubicin—breast cancer	2.25e-05	0.000124	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.25e-05	0.000343	CbGpPWpGaD
Rifaximin—Pruritus—Doxorubicin—breast cancer	2.23e-05	0.000122	CcSEcCtD
Rifaximin—Vomiting—Epirubicin—breast cancer	2.16e-05	0.000119	CcSEcCtD
Rifaximin—Nausea—Methotrexate—breast cancer	2.16e-05	0.000119	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—CYP1A1—breast cancer	2.16e-05	0.00033	CbGpPWpGaD
Rifaximin—Diarrhoea—Doxorubicin—breast cancer	2.16e-05	0.000118	CcSEcCtD
Rifaximin—Rash—Epirubicin—breast cancer	2.15e-05	0.000118	CcSEcCtD
Rifaximin—Dermatitis—Epirubicin—breast cancer	2.14e-05	0.000118	CcSEcCtD
Rifaximin—Headache—Epirubicin—breast cancer	2.13e-05	0.000117	CcSEcCtD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	2.13e-05	0.000325	CbGpPWpGaD
Rifaximin—Dizziness—Doxorubicin—breast cancer	2.08e-05	0.000114	CcSEcCtD
Rifaximin—Nausea—Epirubicin—breast cancer	2.02e-05	0.000111	CcSEcCtD
Rifaximin—Vomiting—Doxorubicin—breast cancer	2e-05	0.00011	CcSEcCtD
Rifaximin—Rash—Doxorubicin—breast cancer	1.99e-05	0.000109	CcSEcCtD
Rifaximin—Dermatitis—Doxorubicin—breast cancer	1.98e-05	0.000109	CcSEcCtD
Rifaximin—Headache—Doxorubicin—breast cancer	1.97e-05	0.000108	CcSEcCtD
Rifaximin—Nausea—Doxorubicin—breast cancer	1.87e-05	0.000103	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—MAPK3—breast cancer	1.82e-05	0.000278	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—MYC—breast cancer	1.77e-05	0.00027	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SYNJ2—breast cancer	1.74e-05	0.000265	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NDUFS3—breast cancer	1.62e-05	0.000246	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CHST9—breast cancer	1.52e-05	0.000232	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—COX11—breast cancer	1.44e-05	0.00022	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SHMT1—breast cancer	1.32e-05	0.000201	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CDA—breast cancer	1.32e-05	0.000201	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC2A5—breast cancer	1.27e-05	0.000193	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.27e-05	0.000193	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—AKT1—breast cancer	1.23e-05	0.000187	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—APRT—breast cancer	1.22e-05	0.000187	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ESRRA—breast cancer	1.15e-05	0.000176	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.15e-05	0.000176	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HADHB—breast cancer	1.09e-05	0.000166	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPI—breast cancer	1.09e-05	0.000166	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.04e-05	0.000159	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.04e-05	0.000159	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—UMPS—breast cancer	9.98e-06	0.000152	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NME1—breast cancer	9.98e-06	0.000152	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FHL2—breast cancer	9.98e-06	0.000152	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADSL—breast cancer	9.98e-06	0.000152	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PHGDH—breast cancer	9.98e-06	0.000152	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HPSE—breast cancer	9.79e-06	0.000149	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—BRIP1—breast cancer	9.79e-06	0.000149	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—LDHB—breast cancer	9.79e-06	0.000149	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMMR—breast cancer	9.28e-06	0.000142	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTA3—breast cancer	9.28e-06	0.000142	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCC1—breast cancer	9.28e-06	0.000142	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARGC1B—breast cancer	8.98e-06	0.000137	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CA9—breast cancer	8.48e-06	0.000129	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTA4—breast cancer	8.48e-06	0.000129	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPX2—breast cancer	8.27e-06	0.000126	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTA2—breast cancer	8.27e-06	0.000126	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPX4—breast cancer	8.17e-06	0.000125	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SULT1A1—breast cancer	8.17e-06	0.000125	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTA1—breast cancer	7.98e-06	0.000122	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—IDH1—breast cancer	7.98e-06	0.000122	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NAT2—breast cancer	7.89e-06	0.00012	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DPYD—breast cancer	6.92e-06	0.000106	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MED12—breast cancer	6.92e-06	0.000106	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDOA—breast cancer	6.81e-06	0.000104	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NCOA3—breast cancer	6.61e-06	0.000101	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC2A2—breast cancer	6.56e-06	0.0001	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCG2—breast cancer	6.43e-06	9.81e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CPT1A—breast cancer	6.43e-06	9.81e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MTR—breast cancer	6.43e-06	9.81e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HPGDS—breast cancer	6.31e-06	9.62e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HBA1—breast cancer	6.27e-06	9.56e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTT1—breast cancer	6.12e-06	9.33e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ACHE—breast cancer	6.12e-06	9.33e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP17A1—breast cancer	5.79e-06	8.83e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ENO1—breast cancer	5.73e-06	8.75e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS1—breast cancer	5.73e-06	8.75e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP2D6—breast cancer	5.62e-06	8.58e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NCOA2—breast cancer	5.52e-06	8.42e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—FASN—breast cancer	5.35e-06	8.16e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—BCHE—breast cancer	5.33e-06	8.13e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC5A5—breast cancer	5.26e-06	8.03e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—SLC2A1—breast cancer	5.08e-06	7.76e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NQO1—breast cancer	5.08e-06	7.76e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP1B1—breast cancer	4.87e-06	7.44e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.78e-06	7.29e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NCOA1—breast cancer	4.65e-06	7.09e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP19A1—breast cancer	4.58e-06	6.99e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—STK11—breast cancer	4.58e-06	6.99e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—COMT—breast cancer	4.26e-06	6.5e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTP1—breast cancer	4.24e-06	6.47e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—HMOX1—breast cancer	4.18e-06	6.38e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ITPR1—breast cancer	4.17e-06	6.37e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCB1—breast cancer	4.01e-06	6.12e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—TYMS—breast cancer	3.94e-06	6.01e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.9e-06	5.94e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NCOR1—breast cancer	3.9e-06	5.94e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GSTM1—breast cancer	3.9e-06	5.94e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GPX1—breast cancer	3.73e-06	5.69e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP1A1—breast cancer	3.69e-06	5.64e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ERCC2—breast cancer	3.66e-06	5.59e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MTHFR—breast cancer	3.44e-06	5.25e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CAV1—breast cancer	3.18e-06	4.85e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CG—breast cancer	2.89e-06	4.41e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CD—breast cancer	2.54e-06	3.88e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALB—breast cancer	2.51e-06	3.83e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—NOS3—breast cancer	2.4e-06	3.66e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CB—breast cancer	2.22e-06	3.38e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS2—breast cancer	2.2e-06	3.35e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTEN—breast cancer	1.92e-06	2.92e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PIK3CA—breast cancer	1.35e-06	2.06e-05	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—AKT1—breast cancer	1.1e-06	1.68e-05	CbGpPWpGaD
